genprowebdirectory
Skip to content
Facebook
LinkedIn
RSS
Twitter/X
YouTube
GEN Edge
Featured News
Multimedia
Content
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits & Spotlights
Webinars
GEN Live
Learning Labs
Podcasts
Videos
Resources
A-Lists
eBooks/Perspectives
Tutorials
New Products
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Toggle Search
Search for:
Search
Search
Toggle Mobile Menu
Toggle Search
×
GEN Edge
Expand submenu
Featured News
Multimedia
Content
Expand submenu
News
Insights
Topics
Expand submenu
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Expand submenu
Browse Issues
Subscribe
Multimedia
Expand submenu
Summits & Spotlights
Webinars
GEN Live
Learning Labs
Podcasts
Videos
Resources
Expand submenu
A-Lists
eBooks/Perspectives
Tutorials
New Products
Subscribe
Expand submenu
Get GEN Magazine
Get GEN eNewsletters
×
Search for:
Search
Search
Home
Authors
Posts by Kevin Davies, PhD
Kevin Davies, PhD
Genome Editing
ASGCT 2024: Gene Therapy Delivery and Development Dominates Opening Workshop
Touching Base
DNA Day: Deep Dive
Genome Editing
On the Charge: MaxCyte Celebrates Role in Sickle Cell Therapy Breakthrough
Genome Editing
Sickle Cell Salvation: The Victoria Gray Interview
Artificial Intelligence
Scenes from SLAS: AI, Organs-on-Chips Resonate at Record Lab Automation Show
Drug Discovery
Going Small: Kymera’s Juliet Williams Touts Degrader Advantage in SLAS 2024 Keynote
Drug Discovery
SLAS 2024: Advances in Automation, Emerging Trends, and More
Genome Editing
FDA Approves the First CRISPR Therapy for Sickle Cell Disease
Touching Base
J.P. Morgan 2024: Illumina, 10x, Danaher, AI; Liberate Bio
Touching Base
Autism, AI and Epigenetics with Nevan Krogan
Genome Editing
FDA Approves Casgevy, the First CRISPR Therapy, for Sickle Cell Disease
Industry News
2023 Year in Review: An Exciting Moment in CRISPR-Land
Industry News
2023 Year in Review: Biotechnology Developments
Genome Editing
The First CRISPR Drug: Vertex Pharmaceuticals’ Casgevy Wins U.K. Approval for Sickle Cell Disease
Genome Editing
ASHG President Brendan Lee Celebrates 75 Years of Research in Genetics and Genomics
Genome Editing
CRISPR Prime Time? FDA Advisory Committee Evaluates Vertex Exa-Cel Therapy for Sickle Cell Disease
Genome Editing
Delta Force: Scientists Promote Novel Globin Genetic Therapy for Sickle Cell Disease
Genome Editing
ASGCT News: David Liu Hails Rapid Progress in Precision Genome Editing
Genome Editing
ASGCT News: Hematologist David Williams Wins 2023 ASGCT Founder’s Award
Genome Editing
Search and Replace: Andrew Anzalone Details How Genome Editing Went Prime Time on “Close to the Edge”
<
1
2
3
4
5
6
7
>
Page 4 of 7